Association Between TFPI Polymorphisms and VTE Risk Unclear

MedWire News -- Polymorphisms in the tissue factor pathway inhibitor type 1 gene (TFPI) modify the expression of its protein, which may in turn increase the risk for venous thromboembolism (VTE), according to Norwegian researchers.